Noriko Iikuni

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint The influence of sex on patients with rheumatoid arthritis in a large observational cohort
    Noriko Iikuni
    University of California, Los Angeles, Department of Medicine, Los Angeles, CA 90095, USA
    J Rheumatol 36:508-11. 2009
  2. ncbi request reprint Potential for anti-DNA immunoglobulin peptide therapy in systemic lupus erythematosus
    Noriko Iikuni
    University of California Los Angeles, Division of Rheumatology, Department of Medicine, 1000 Veteran Avenue 32 59, Los Angeles, California 90095 1670, USA
    Expert Opin Biol Ther 9:201-6. 2009
  3. ncbi request reprint Antibody-based therapies in systemic lupus erythematosus
    Noriko Iikuni
    Division of Rheumatology, Department of Medicine, University of California Los Angeles, 1000 Veteran Avenue 32 59, Los Angeles, California 90095 1670, USA
    Mini Rev Med Chem 9:829-46. 2009
  4. doi request reprint Regulatory CD4+ T cells promote B cell anergy in murine lupus
    Yaoyang Liu
    Division of Rheumatology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095
    J Immunol 192:4069-73. 2014
  5. pmc Modulation of p38 MAPK activity in regulatory T cells after tolerance with anti-DNA Ig peptide in (NZB x NZW)F1 lupus mice
    Elaine V Lourenço
    Division of Rheumatology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA
    J Immunol 182:7415-21. 2009
  6. pmc Leptin enhances availability of apoptotic cell-derived self-antigen in systemic lupus erythematosus
    Gil Amarilyo
    University of California Los Angeles, California, Los Angeles, United States of America
    PLoS ONE 9:e112826. 2014
  7. doi request reprint Leptin promotes lupus T-cell autoimmunity
    Gil Amarilyo
    Department of Medicine, University of California at Los Angeles, CA, USA
    Clin Immunol 149:530-3. 2013
  8. pmc Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus
    Noriko Iikuni
    Division of Rheumatology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
    J Immunol 183:1518-22. 2009
  9. pmc Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis
    Jennifer M P Woo
    Department of Medicine Rheumatology, David Geffen School of Medicine, University of California, 1000 Veteran Avenue, Los Angeles, CA 90095, USA
    Arthritis Res Ther 12:R93. 2010

Collaborators

Detail Information

Publications9

  1. doi request reprint The influence of sex on patients with rheumatoid arthritis in a large observational cohort
    Noriko Iikuni
    University of California, Los Angeles, Department of Medicine, Los Angeles, CA 90095, USA
    J Rheumatol 36:508-11. 2009
    ..To compare the sex differences of various components of rheumatoid arthritis (RA)...
  2. ncbi request reprint Potential for anti-DNA immunoglobulin peptide therapy in systemic lupus erythematosus
    Noriko Iikuni
    University of California Los Angeles, Division of Rheumatology, Department of Medicine, 1000 Veteran Avenue 32 59, Los Angeles, California 90095 1670, USA
    Expert Opin Biol Ther 9:201-6. 2009
    ..Some patients may not respond well to some treatments because of inter-individual variability of the disease. More specific and safer therapies are needed...
  3. ncbi request reprint Antibody-based therapies in systemic lupus erythematosus
    Noriko Iikuni
    Division of Rheumatology, Department of Medicine, University of California Los Angeles, 1000 Veteran Avenue 32 59, Los Angeles, California 90095 1670, USA
    Mini Rev Med Chem 9:829-46. 2009
    ..This review provides an update on the ongoing clinical trials and the promise and obstacles in the use of biologics in SLE...
  4. doi request reprint Regulatory CD4+ T cells promote B cell anergy in murine lupus
    Yaoyang Liu
    Division of Rheumatology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095
    J Immunol 192:4069-73. 2014
    ..These findings identify a new mechanism by which Tregs can control production of autoantibodies in lupus B cells and, more generally, B cell activity in physiopathological conditions. ..
  5. pmc Modulation of p38 MAPK activity in regulatory T cells after tolerance with anti-DNA Ig peptide in (NZB x NZW)F1 lupus mice
    Elaine V Lourenço
    Division of Rheumatology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA
    J Immunol 182:7415-21. 2009
    ..Transfer experiments confirmed the role of p38 in Tregs on disease activity in the NZB/W mice. These data indicate that the modulation of p38 activity in lupus Tregs can significantly influence the disease activity...
  6. pmc Leptin enhances availability of apoptotic cell-derived self-antigen in systemic lupus erythematosus
    Gil Amarilyo
    University of California Los Angeles, California, Los Angeles, United States of America
    PLoS ONE 9:e112826. 2014
    ..As leptin promotes macrophage phagocytosis of apoptotic bodies in SLE and subsequent availability of apoptotic-derived antigen to T cells, an inhibition of this process via leptin blockade might have a therapeutic potential in SLE. ..
  7. doi request reprint Leptin promotes lupus T-cell autoimmunity
    Gil Amarilyo
    Department of Medicine, University of California at Los Angeles, CA, USA
    Clin Immunol 149:530-3. 2013
    ..This ability of leptin to promote lupus T-cell autoimmunity suggests the possibility of a therapeutic targeting of leptin in SLE. ..
  8. pmc Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus
    Noriko Iikuni
    Division of Rheumatology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
    J Immunol 183:1518-22. 2009
    ..These results indicate that one way by which natural Tregs attempt to limit humoral autoimmunity in SLE is by directly targeting autoreactive B cells...
  9. pmc Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis
    Jennifer M P Woo
    Department of Medicine Rheumatology, David Geffen School of Medicine, University of California, 1000 Veteran Avenue, Los Angeles, CA 90095, USA
    Arthritis Res Ther 12:R93. 2010
    ....